Life ScienceCompany
Surepharm Ownership
Who owns Surepharm?
Surepharm is owned by Chiltern Capital and Souter Investments Limited. It was acquired on January 1, 2022.
Is Surepharm PE-backed?
Yes. Surepharm is owned by private equity investors Chiltern Capital and Souter Investments Limited.
Surepharm Business Overview
Where is Surepharm headquartered?
Surepharm is headquartered in Staffordshire, United Kingdom.
What sector is Surepharm in?
Surepharm is a life science company.
Life Science M&A Summary in 2022
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.
Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.